Gábor Balázsi, PhD, a prominent Biomedical Engineering professor at Stony Brook University, has been accorded the honor of being named a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). The recognition was conferred during an induction ceremony for the 2025 Class of College Fellows in Arlington, Virginia, on March 31.
The AIMBE College of Fellows is notable for including "171 leading international scientists," some of whom are Nobel Prize recipients or have received the Presidential Medal of Science and/or Technology and Innovation. Membership also includes "233 Fellows have been inducted to the National Academy of Engineering, 120 into to the National Academy of Medicine, and 51 inducted to the National Academy of Sciences."
Balázsi was selected for his "pioneering contributions to apply engineering principles to design protein-level tuning synthetic gene circuits, and to identify mechanisms for their evolution." His academic role includes serving as the Henry Laufer Professor of Physical and Quantitative Biology and professor in the Department of Biomedical Engineering. He is also an affiliate member of the Stony Brook University Cancer Center.
Balázsi's research focuses on synthetic gene circuits, aimed at fostering a better understanding of biological processes such as cellular decision-making and the evolution of cell populations, which are relevant in areas like metastatic progression and cancer chemoresistance. His work has been featured in approximately 50 journals, including "Nature Communications, Nature Chemical Biology, PNAS, Cell, and Cell Chemical Biology."
Active in professional circles, Balázsi is affiliated with the American Physical Society, the American Association for Cancer Research, and the American Association for the Advancement of Science.
Comprised of nearly 3,000 members, AIMBE’s College of Fellows significantly contributes to advancements in medical and biological engineering on a global scale, representing over 30 countries.